Calsona, Mia Monique A.

HRN: 28-42-96  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/26/2026
03/02/2026
IV
500 Mg
Q6
Wound Dehiscence Sp Episiorhaphy
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: